(Q38157648)

English

Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

0 references

Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

based on heuristic

inferred from title

Lobular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Fausto Petrelli

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sandro Barni

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

language of work or name

0 references

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

142

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

227-235

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Clinicopathologic characteristics of invasive lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Response-guided neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2751-3

21 January 2018

Identifiers

10.1007/S10549-013-2751-3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38157648&oldid=2201336097"